A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
Y. Chiu, C. Tang, S. Hung, Y. Yang, C. Fang, H. Lin
深入研究「A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study」主題。共同形成了獨特的指紋。